TERLIVAZ
Dead / Cancelled — Cancelled — Section 8 (as of 19 Nov 2021)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85876469
- Registration number
- 4720688
- Mark type
- Stylized text
- Filed
- 14 Mar 2013
- Published for opposition
- 30 Jul 2013
- Registered
- 14 Apr 2015
- Attorney of record
- Andrew N. Spivak
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical drugs for the treatment of hepatorenal syndrome (HRS)
Owner
- MALLINCKRODT CRITICAL CARE FINANCE INC., HAZELWOOD, MO, US
- MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED, DUBLIN, IE
- Ikaria Therapeutics LLC, Hampton, NJ, US
- Ikaria Therapeutics LLC, Hampton, NJ, US
- Ikaria Therapeutics LLC, Hampton, NJ, US
Prosecution history
- 22 Nov 2023 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 13 Jul 2022 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 19 Nov 2021 — CANCELLED SEC. 8 (6-YR)
- 22 Jul 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 13 May 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 14 Apr 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 31 Jul 2019 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 22 Apr 2015 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 14 Apr 2015 — REGISTERED-PRINCIPAL REGISTER
- 10 Mar 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Mar 2015 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Mar 2015 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Mar 2015 — USE AMENDMENT FILED
- 03 Mar 2015 — TEAS STATEMENT OF USE RECEIVED
- 23 Sept 2014 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED